USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Analysis of Top 10 Specialty Pharmaceutical Companies
Analysis of Top 10 Specialty Pharmaceutical Companies
RELEASE DATE
28-Apr-2006
28-Apr-2006
REGION
North America
North America
Research Code: F625-01-00-00-00
SKU: HC01486-NA-MR_06042
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC01486-NA-MR_06042
Description
This research service provides a detailed overview and analysis of ten specialty pharmaceutical companies. They have been chosen by taking into account certain critical indicators such as revenues, research and development (R&D) expenditure, current drug pipeline, earnings per share, stock price appreciation, return on investment, and net income.
Table of Contents
Executive Summary
- Executive Summary
Market Overview
- Top Ten Specialty Pharmaceutical Companies
- Market Structure
- Research Methodology
Frost & Sullivan Awards
- Growth Strategy Leadership Award
- Market Leadership Award
- Product Line Strategy Award
Teva Pharmaceutical Industries Ltd
Forest Laboratories Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Allergan Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Watson Pharmaceuticals Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Shire Pharmaceuticals Group
- Company Profile
- Product Analysis
- SWOT Analysis
King Pharmaceuticals Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Andrx Corporation
- Company Profile
- Product Analysis
- SWOT Analysis
Barr Pharmaceuticals Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Cephalon Inc
- Company Profile
- Product Analysis
- SWOT Analysis
Endo Pharmaceuticals
- Company Profile
- Product Analysis
- SWOT Analysis
Pharmaceuticals and Biotechnology
Popular Topics
This research service provides a detailed overview and analysis of ten specialty pharmaceutical companies. They have been chosen by taking into account certain critical indicators such as revenues, research and development (R&D) expenditure, current drug pipeline, earnings per share, stock price appreciation, return on investment, and net income.
| No Index | No |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F625-01-00-00-00 |
| Is Prebook | No |